Globus Medical (GMED) Cash Flow Statement

A cash flow statement shows the actual cash a company generated and spent across operating, investing, and financing activities over a reporting period.

Globus Medical, Inc. develops and commercializes healthcare solutions for patients with musculoskeletal disorders in the United States and internationally.

Total Cash From Operating Activities Chart for Globus Medical

Globus Medical (GMED) operating cash flow for FY2025 was USD 753.4M, a 44.7% change from FY2024. Globus Medical's operating cash flow grew from USD 32.1M in 2009 to USD 753.4M in 2025 (2248.7% over 16 years). Operating cash flow compound annual growth rate: 5-year CAGR of 30.5%, 10-year CAGR of 20.0%.

The most recent 3 years are real; the rest is blurred as a preview. Sign up free to unlock every line item, quarterly data, and the real full history. Free account: 8 years of history for 10 flagship companies. Premium: full history for 500+ companies. Premium is €10.00/month. See pricing.

Total Cash From Operating Activities (US Dollars)

R&D as % of Revenue

Key Stats

Market Cap
$10.26B
Implied Share Price
$91.76
Enterprise Value
$9.45B
Revenue (TTM)
$3.14B
EBITDA
$1.01B
Profit Margin
17.03%
Trailing P/E
19.60
Forward P/E
13.87
Price/Book (MRQ)
2.08
Price/Sales (TTM)
3.26
EV/EBITDA
9.90
EV/Revenue
3.00
Dividend Yield
—
Book Value
$35.52
Free Cash Flow (FY2025)
$588.77M
Free Cash Flow Yield
5.74%

Snapshot as of 7th October 2026 — not point-in-time controlled, may lag the live market by a few days.